Investor Relations –

Events &
Presentations

Presentations –

Presentations.

Date Title Files
Nov 9, 2026
PIKTOR Phase 2 Endometrial Cancer Topline Results November 2026
Nov 9, 2026
Faeth Corporate Presentation November 2026
Oct 6, 2026
Inaugural Investor/ Analyst Day Presentation October 2026
Aug 8, 2026
Exposure/Response Analysis of an Oral Multi-Node PI3K/AKT/mTOR Pathway Inhibitor Combination of Serabelisib and Sapanisertib

The drug product candidates described on this website are investigational agents that have not been approved by the Food and Drug Administration or any other regulatory authority. Their safety and efficacy have not been established.